Compare PBH & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | CBUS |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 69.9M |
| IPO Year | 2005 | 2017 |
| Metric | PBH | CBUS |
|---|---|---|
| Price | $61.48 | $1.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $86.40 | $20.00 |
| AVG Volume (30 Days) | ★ 429.1K | 168.2K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | ★ $1,110,479,000.00 | $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.50 | $109.96 |
| P/E Ratio | $15.19 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $57.25 | $1.09 |
| 52 Week High | $90.04 | $4.24 |
| Indicator | PBH | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 57.01 |
| Support Level | $59.52 | $1.50 |
| Resistance Level | $62.14 | $1.75 |
| Average True Range (ATR) | 1.55 | 0.14 |
| MACD | 0.32 | 0.04 |
| Stochastic Oscillator | 86.90 | 69.23 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.